Coca-Cola HBC AG (LON:CCH – Get Rating) insider Zoran Bogdanovic purchased 167 shares of Coca-Cola HBC stock in a transaction dated Wednesday, May 17th. The stock was bought at an average cost of GBX 2,572 ($32.22) per share, with a total value of £4,295.24 ($5,380.48).
Zoran Bogdanovic also recently made the following trade(s):
- On Monday, April 17th, Zoran Bogdanovic bought 183 shares of Coca-Cola HBC stock. The shares were acquired at an average price of GBX 2,345 ($29.37) per share, for a total transaction of £4,291.35 ($5,375.61).
- On Thursday, March 30th, Zoran Bogdanovic sold 35,000 shares of Coca-Cola HBC stock. The stock was sold at an average price of GBX 2,230 ($27.93), for a total value of £780,500 ($977,702.62).
- On Wednesday, March 22nd, Zoran Bogdanovic sold 28,408 shares of Coca-Cola HBC stock. The stock was sold at an average price of GBX 2,192 ($27.46), for a total value of £622,703.36 ($780,036.78).
- On Thursday, March 16th, Zoran Bogdanovic bought 206 shares of Coca-Cola HBC stock. The shares were acquired at an average price of GBX 2,109 ($26.42) per share, for a total transaction of £4,344.54 ($5,442.24).
- On Friday, February 24th, Zoran Bogdanovic sold 30,000 shares of Coca-Cola HBC stock. The stock was sold at an average price of GBX 2,145 ($26.87), for a total value of £643,500 ($806,087.94).
- On Tuesday, February 21st, Zoran Bogdanovic sold 7,267 shares of Coca-Cola HBC stock. The stock was sold at an average price of GBX 2,090 ($26.18), for a total value of £151,880.30 ($190,254.67).
- On Friday, February 17th, Zoran Bogdanovic bought 206 shares of Coca-Cola HBC stock. The shares were acquired at an average price of GBX 2,071 ($25.94) per share, for a total transaction of £4,266.26 ($5,344.18).
Coca-Cola HBC Stock Performance
Shares of CCH stock opened at GBX 2,548 ($31.92) on Friday. The stock has a market cap of £9.35 billion, a PE ratio of 2,573.74, a price-to-earnings-growth ratio of 2.36 and a beta of 0.97. The business has a 50-day simple moving average of GBX 2,333.88 and a 200-day simple moving average of GBX 2,113.39. The company has a quick ratio of 0.80, a current ratio of 1.24 and a debt-to-equity ratio of 101.01. Coca-Cola HBC AG has a 52-week low of GBX 1,660.50 ($20.80) and a 52-week high of GBX 2,582 ($32.34).
Coca-Cola HBC Increases Dividend
Wall Street Analyst Weigh In
Several research analysts recently weighed in on CCH shares. Numis Securities restated an “add” rating and set a GBX 2,200 ($27.56) target price on shares of Coca-Cola HBC in a research note on Tuesday, February 14th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 2,800 ($35.07) price target on shares of Coca-Cola HBC in a research note on Wednesday, March 22nd. Citigroup reiterated a “neutral” rating and set a GBX 2,270 ($28.44) price target on shares of Coca-Cola HBC in a research note on Tuesday, April 4th. Deutsche Bank Aktiengesellschaft dropped their price target on Coca-Cola HBC from GBX 2,580 ($32.32) to GBX 2,545 ($31.88) and set a “buy” rating on the stock in a research note on Tuesday, April 4th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a GBX 2,200 ($27.56) price target on shares of Coca-Cola HBC in a research note on Tuesday, April 4th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,452.50 ($30.72).
About Coca-Cola HBC
Coca-Cola HBC AG engages in the production, distribution, and sale of non-alcoholic ready-to-drink beverages worldwide. The company offers sparkling soft drinks, hydration drinks, juices, ready-to-drink tea, energy drinks, coffee, water, plant-based drinks, premium spirits and flavored alcoholic beverages, and snacks.
Further Reading
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Receive News & Ratings for Coca-Cola HBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coca-Cola HBC and related companies with MarketBeat.com's FREE daily email newsletter.